StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Roche Holding AG
Swiss Stock Exchange:RO.SW
Sector
Location
Market Cap
USD 258.10 B
Share Price
USD 342.36
Avg Daily Volume
28,734
Change (1 day)
0.03%
Change (1 year)
14.78%
Change (YTD)
14.42%
Roche Holding AG Operating Cash Flow for the year ending December 31, 2024: USD 22.13 B
Roche Holding AG Operating Cash Flow is USD 22.13 B for the year ending December 31, 2024, a 15.74% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Roche Holding AG Operating Cash Flow for the year ending December 31, 2023 was USD 19.12 B, a -1.19% change year over year.
-
Roche Holding AG Operating Cash Flow for the year ending December 31, 2022 was USD 19.35 B, a -14.19% change year over year.
-
Roche Holding AG Operating Cash Flow for the year ending December 31, 2021 was USD 22.55 B, a 9.91% change year over year.
-
Roche Holding AG Operating Cash Flow for the year ending December 31, 2020 was USD 20.51 B, a -11.23% change year over year.
Competitors
AbbVie Inc.
USD 189.77
ABBV
+2.14
1.14%
Novo Nordisk A/S
USD 70.59
NOVO-B.CO
+1.50
2.17%
Novartis AG
USD 122.54
NOVN.SW
+0.43
0.36%
Abbott Laboratories
USD 133.36
ABT
-0.34
-0.25%
AstraZeneca PLC
USD 140.42
AZN.L
+1.47
1.06%
Merck & Co., Inc.
USD 81.37
MRK
+0.47
0.58%
Amgen Inc.
USD 297.00
AMGN
+4.05
1.38%
Pfizer Inc.
USD 25.62
PFE
+0.38
1.51%
Gilead Sciences, Inc.
USD 111.06
GILD
-0.72
-0.64%
Vertex Pharmaceuticals Incorporated
USD 466.36
VRTX
+6.95
1.51%
Sanofi
USD 97.70
SAN.PA
+1.18
1.22%
Bristol-Myers Squibb Company
USD 47.04
BMY
+0.55
1.18%
Chugai Pharmaceutical Co., Ltd.
USD 46.38
4519.T
-0.70
-1.48%
CSL Limited
USD 159.49
CSL.AX
-1.10
-0.69%
GSK plc
USD 19.20
GSK.L
+0.23
1.19%
Regeneron Pharmaceuticals, Inc.
USD 547.75
REGN
+9.64
1.79%
MERCK Kommanditgesellschaft auf Aktien
USD 130.84
MRK.DE
+2.82
2.20%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.44
600276.SS
+0.11
1.44%
Takeda Pharmaceutical Company Limited
USD 29.98
4502.T
+0.01
0.04%
Alnylam Pharmaceuticals, Inc.
USD 317.50
ALNY
-6.63
-2.04%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
AbbVie Inc.
USD 189.77
ABBV
+2.14
1.14%
Novo Nordisk A/S
USD 70.59
NOVO-B.CO
+1.50
2.17%
Novartis AG
USD 122.54
NOVN.SW
+0.43
0.36%
Abbott Laboratories
USD 133.36
ABT
-0.34
-0.25%
AstraZeneca PLC
USD 140.42
AZN.L
+1.47
1.06%
Merck & Co., Inc.
USD 81.37
MRK
+0.47
0.58%
Amgen Inc.
USD 297.00
AMGN
+4.05
1.38%
Pfizer Inc.
USD 25.62
PFE
+0.38
1.51%
Gilead Sciences, Inc.
USD 111.06
GILD
-0.72
-0.64%
Vertex Pharmaceuticals Incorporated
USD 466.36
VRTX
+6.95
1.51%
Sanofi
USD 97.70
SAN.PA
+1.18
1.22%
Bristol-Myers Squibb Company
USD 47.04
BMY
+0.55
1.18%
Chugai Pharmaceutical Co., Ltd.
USD 46.38
4519.T
-0.70
-1.48%
CSL Limited
USD 159.49
CSL.AX
-1.10
-0.69%
GSK plc
USD 19.20
GSK.L
+0.23
1.19%
Regeneron Pharmaceuticals, Inc.
USD 547.75
REGN
+9.64
1.79%
MERCK Kommanditgesellschaft auf Aktien
USD 130.84
MRK.DE
+2.82
2.20%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.44
600276.SS
+0.11
1.44%
Takeda Pharmaceutical Company Limited
USD 29.98
4502.T
+0.01
0.04%
Alnylam Pharmaceuticals, Inc.
USD 317.50
ALNY
-6.63
-2.04%